Integrated Diagnostics Holdings PLC (LSE:IDHC) — Market Cap & Net Worth

$318.57 Million USD  · Rank #14569

Market Cap & Net Worth: Integrated Diagnostics Holdings PLC (IDHC)

Integrated Diagnostics Holdings PLC (LSE:IDHC) has a market capitalization of $318.57 Million ($318.57 Million) as of September 16, 2026. Listed on the LSE stock exchange, this UK-based company holds position #14569 globally and #73 in its home market, demonstrating a -0.36% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Integrated Diagnostics Holdings PLC's stock price $0.55 by its total outstanding shares 581326272 (581.33 Million). Also see Integrated Diagnostics Holdings PLC asset portfolio for a full breakdown of the balance sheet.

Integrated Diagnostics Holdings PLC Market Cap History: 2015 to 2026

Integrated Diagnostics Holdings PLC's market capitalization history from 2015 to 2026. Data shows change from $503.95 Million to $318.57 Million (-5.77% CAGR). Also see Integrated Diagnostics Holdings PLC (IDHC) cash flow conversion for how efficiently the company converts equity into cash flow.

Integrated Diagnostics Holdings PLC Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Integrated Diagnostics Holdings PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Integrated Diagnostics Holdings PLC for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.04x

Integrated Diagnostics Holdings PLC's market cap is 0.04 times its annual revenue

Industry average: 0.63x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.24x

Integrated Diagnostics Holdings PLC's market cap is 0.24 times its annual earnings

Industry average: 2.27x Lower than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2015 $503.95 Million $1.01 Billion $144.87 Million 0.50x 3.48x
2016 $348.39 Million $1.17 Billion $260.40 Million 0.30x 1.34x
2017 $502.03 Million $1.51 Billion $374.02 Million 0.33x 1.34x
2018 $464.94 Million $1.92 Billion $502.09 Million 0.24x 0.93x
2019 $463.38 Million $2.23 Billion $510.93 Million 0.21x 0.91x
2020 $535.40 Million $2.66 Billion $594.01 Million 0.20x 0.90x
2021 $673.29 Million $5.22 Billion $1.41 Billion 0.13x 0.48x
2022 $368.56 Million $3.61 Billion $541.11 Million 0.10x 0.68x
2023 $206.37 Million $4.12 Billion $510.30 Million 0.05x 0.40x
2024 $254.04 Million $5.72 Billion $1.08 Billion 0.04x 0.24x

Competitor Companies of IDHC by Market Capitalization

Companies near Integrated Diagnostics Holdings PLC in the global market cap rankings as of September 16, 2026. Review Integrated Diagnostics Holdings PLC (IDHC) tangible net worth to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Integrated Diagnostics Holdings PLC by market ranking:

  • Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #88 globally with a market cap of $224.59 Billion USD.
  • Danaher Corporation (NYSE:DHR): Ranked #161 globally with a market cap of $147.88 Billion USD.
  • WuXi AppTec Co Ltd (SHG:603259): Ranked #476 globally with a market cap of $56.70 Billion USD ( CN¥387.49 Billion CNY).
  • Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#88 Thermo Fisher Scientific Inc NYSE:TMO $224.59 Billion $641.39
#161 Danaher Corporation NYSE:DHR $147.88 Billion $209.36
#476 WuXi AppTec Co Ltd SHG:603259 $56.70 Billion CN¥156.67
#578 Natera Inc NASDAQ:NTRA $47.01 Billion $350.78

Integrated Diagnostics Holdings PLC Historical Marketcap From 2015 to 2026

Between 2015 and today, Integrated Diagnostics Holdings PLC's market cap moved from $503.95 Million to $ 318.57 Million, with a yearly change of -5.77%.

Year Market Cap Change (%)
2026 $318.57 Million -26.44%
2025 $433.09 Million +70.48%
2024 $254.04 Million +23.10%
2023 $206.37 Million -44.01%
2022 $368.56 Million -45.26%
2021 $673.29 Million +25.75%
2020 $535.40 Million +15.54%
2019 $463.38 Million -0.34%
2018 $464.94 Million -7.39%
2017 $502.03 Million +44.10%
2016 $348.39 Million -30.87%
2015 $503.95 Million --

End of Day Market Cap According to Different Sources

On Sep 16th, 2026 the market cap of Integrated Diagnostics Holdings PLC was reported to be:

Source Market Cap
Yahoo Finance $318.57 Million USD
MoneyControl $318.57 Million USD
MarketWatch $318.57 Million USD
marketcap.company $318.57 Million USD
Reuters $318.57 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Integrated Diagnostics Holdings PLC

LSE:IDHC UK Diagnostics & Research
Market Cap
$318.57 Million
Market Cap Rank
#14569 Global
#73 in UK
Share Price
$0.55
Change (1 day)
+1.48%
52-Week Range
$0.46 - $0.79
All Time High
$1.22
About

Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron… Read more